Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.50
Delayed Data
As of Feb 27
 -0.27 / -3.47%
Today’s Change
4.71
Today|||52-Week Range
9.62
0.00%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close7.77
Today’s open7.65
Day’s range7.50 - 7.88
Volume6,315
Average volume (3 months)11,320
Market cap$70.9M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+29.03%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-90.00%
P/E ratioNM
Price/Sales2,908.69
Price/Book4.55

Competitors

 Today’s
change
Today’s
% change
CBRXColumbia Laboratorie...-0.45-6.09%
PTBIPlasmaTech Biopharma...+0.18+5.77%
APDNApplied DNA Sciences...+0.25+6.87%
NMUSNemus Bioscience Inc0.000.00%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$10.0K
Annual profit (last year)-$7.6M
Net profit margin-76,431.24%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Chief Financial Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account